Expression of LEF1 in mantle cell lymphoma.

[1]  K. Young,et al.  High LEF1 expression predicts adverse prognosis in chronic lymphocytic leukemia and may be targeted by ethacrynic acid , 2016, Oncotarget.

[2]  A. Tzankov,et al.  LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma , 2015, Journal of Clinical Pathology.

[3]  N. Aguilera,et al.  New immunohistochemistry for B-cell lymphoma and Hodgkin lymphoma. , 2014, Archives of pathology & laboratory medicine.

[4]  A. Tsimberidou,et al.  Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma , 2013 .

[5]  R. Spang,et al.  Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt's lymphoma. , 2013, The American journal of pathology.

[6]  E. Thiel,et al.  Overexpression of LEF1 predicts unfavorable outcome in adult patients with B-precursor acute lymphoblastic leukemia. , 2011, Blood.

[7]  L. Peterson,et al.  Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas , 2011, Modern Pathology.

[8]  K. Kreuzer,et al.  High lymphoid enhancer-binding factor-1 expression is associated with disease progression and poor prognosis in chronic lymphocytic leukemia , 2010, Hematology reports.

[9]  J. Schweizer,et al.  On the regulation of hair keratin expression: lessons from studies in pilomatricomas. , 2004, The Journal of investigative dermatology.

[10]  A. López-Guillermo,et al.  Mantle cell lymphoma , 1998, Cancer.

[11]  E. Campo,et al.  Mantle cell lymphoma: evolving management strategies. , 2015, Blood.